Evidence map›Paper›PMID 40236091›Full record

ArticlebioRxiv : the preprint server for biology2025

Loss of

Naitao Wang, Dan Li, Tao Zhang, Mohini R Pachai, Woo Hyun Cho, Makhzuna N Khudoynazarova, Dana M Schoeps, Yudi Bao, Marion Liu, Laura Tang and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Naitao Wang
Dan Li
Tao Zhang
Mohini R Pachai
Woo Hyun Cho
Makhzuna N Khudoynazarova
Dana M Schoeps
Yudi Bao
Marion Liu
Laura Tang
Janjigian Yelena
Ping Chi

Funding

Understanding and targeting MAPK pathway activation in NF1-deficient malignant peripheral nerve sheath tumor (MPNST)U01CA252048 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CHI, PING · 2021 to 2025
$3.1M
Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancerR01CA280657 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Ping Chi · 2023 to 2026
$2.9M
Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancerR01CA228216 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CHI, PING · 2018 to 2022
$2.5M
NCI NIH HHS R01 CA228216NCI NIH HHS R01 CA280657NCI NIH HHS U01 CA252048
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40236091
PMCPMC11996406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.